| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_LPAR1_0006500 | Intron-Intron | chr9:113771428-113779408 | chr9:111009148-111017128 | 54 nt | 0.2963 |
| hsa_LPAR1_0006200 | Intron-Intron | chr9:113771428-113783270 | chr9:111009148-111020990 | 250 nt | 0.2560 |
| hsa_LPAR1_0006600 | Intron-Intron | chr9:113771428-113787276 | chr9:111009148-111024996 | 54 nt | 0.2963 |
| hsa_LPAR1_0006700 | Intron-Intron | chr9:113771428-113798297 | chr9:111009148-111036017 | 28 nt | 0.3214 |
| hsa_LPAR1_0006800 | Intron-Intron | chr9:113771428-113798481 | chr9:111009148-111036201 | 134 nt | 0.4403 |
| hsa_LPAR1_0006900 | Intron-Intron | chr9:113772456-113773970 | chr9:111010176-111011690 | 165 nt | 0.3576 |
| hsa_LPAR1_0007100 | Intron-Intron | chr9:113778323-113778472 | chr9:111016043-111016192 | 150 nt | 0.4467 |
| hsa_LPAR1_0007200 | Intron-Intron | chr9:113779256-113798481 | chr9:111016976-111036201 | 250 nt | 0.4040 |
| hsa_LPAR1_0007300 | Intron-Intron | chr9:113779612-113798481 | chr9:111017332-111036201 | 293 nt | 0.3925 |
| hsa_LPAR1_0007400 | Intron-Intron | chr9:113798190-113798481 | chr9:111035910-111036201 | 108 nt | 0.3704 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].